logo-loader
viewAdvanced Oncotherapy PLC

Advanced Oncotherapy unveils collaboration with University Hospitals Birmingham NHS Foundation Trust

It’s a fourth significant tie-up for AVO and follows on from agreements with the Cleveland Clinic, The London Clinic and the Mediterranean Hospital of Limassol

Advanced Oncotherapy PLC -

Advanced Oncotherapy PLC (LON:AVO) has unveiled a collaboration that will bring specialist proton beam therapy to the West Midlands.

The company is to install its LIGHT system in a facility on the campus of University Hospitals Birmingham NHS Foundation Trust (UHB).

It’s a fourth significant tie-up for AVO and follows on from agreements with the Cleveland Clinic, The London Clinic and the Mediterranean Hospital of Limassol.

Chief executive Nicolas Serandour said UBH was a leader in the “non-surgical cancer treatment field”.

As such the pair will work together on “various research and development activities…to increase the awareness of proton therapy for the treatment of cancer”.

No commercial details were provided, although AVO confirmed a revenue-sharing arrangement will be implemented.

“The collaboration is aimed at delivering best treatment modalities for patients and further establishes our network of scientific partners, positioning Advanced Oncotherapy at the forefront of clinical innovation,” added CEO Serandour.

“UHB's choice of Advanced Oncotherapy not only strengthens our leading position as technology disruptor in proton therapy, but also demonstrates our strong momentum and the clear opportunity we have to meet a significant unmet medical need.”

Quick facts: Advanced Oncotherapy PLC

Price: 26 GBX

LSE:AVO
Market: LSE
Market Cap: £79.66 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Advanced Oncotherapy One2One Investor Presentation 29th October 2013-DUBLIN

Advanced Oncotherapy One2One Investor Presentation 29th October 2013-DUBLIN

on 10/29/2013

2 min read